| mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |